HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Michel Carrier Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Carrier, M. Articles by Pelletier, L. C. Search for Related Content PubMed PubMed Citation Articles by Carrier, M. Articles by Pelletier, L. C. Related Collections Related Article

Ann Thorac Surg 1996;61:1651-1657
© 1996 The Society of Thoracic Surgeons

---

Original Article: Cardiovascular

Effect of L-Arginine on Metabolic Recovery of the Ischemic Myocardium

Department of Surgery, Montreal Heart Institute, Montreal, Quebec, Canada

Background. The release of nitric oxide is decreased after myocardial ischemia and reperfusion. Whereas the precursor L-arginine can stimulate the release of nitric oxide, its effect on metabolic recovery after myocardial ischemia is unknown.

Methods. To study the effect of L-arginine on metabolic recovery after myocardial ischemia, cardioplegia infusion, and reperfusion, 33 dogs were placed on cardiopulmonary bypass and subjected to a sequence of 30 minutes of normothermic global ischemia, 30 minutes of warm blood cardioplegic arrest, and 30 minutes of reperfusion. A pH probe was inserted in the anterior wall of the left ventricle, and tissue pH was measured throughout the experiment. Coronary blood flow in the left anterior descending coronary artery and the circumflex coronary artery was measured. Blood samples from the coronary sinus were taken to measure blood pH and levels of lactate, creatine kinase, and troponin T.

Results. In the control group of 9 dogs, tissue pH averaged 6.4 ± 0.1, 6.5 ± 0.1, and 6.8 ± 0.1 after the end of global ischemia, cardioplegia, and reperfusion, respectively. Tissue pH averaged 6.4 ± 0.1, 6.6 ± 0.1, and 6.9 ± 0.1, respectively, in the experimental group of 9 animals with 2 mmol/L of L-arginine added to the cardioplegic solution. Tissue pH averaged 6.2 ± 0.1, 6.7 ± 0.1, 7.1 ± 0.1, respectively, in the third group of 9 animals that received an additional infusion of L-arginine (10 mg•kg^-1•min^-1) during reperfusion. Tissue pH recovered faster in groups with L-arginine (p = 0.00001). A hyperemic response of coronary blood flow was shown at reperfusion in animals in the control group only. In 6 dogs, L-NAME (N-nitro-arginine methyl ester), an inhibitor of nitric oxide synthesis, was injected and resulted in a slower pH recovery on reperfusion compared with that of animals that received L-arginine.

Conclusions. The addition of L-arginine to the cardioplegic solution and the systemic circulation during reperfusion resulted in a significant increase in coronary blood flow during cardioplegia infusion and in a faster recovery of myocardial tissue pH, possibly by increasing coronary blood flow through the release of nitric oxide.

Related Article

Discussion
Ann. Thorac. Surg. 1996 61: 1657. [Extract] [Full Text]

This article has been cited by other articles:

				B. Wei, Y. Liu, Q. Wang, C. Yu, C. Long, Y. Chang, and Y. Ruan Lung perfusion with protective solution relieves lung injury in corrections of Tetralogy of Fallot Ann. Thorac. Surg., March 1, 2004; 77(3): 918 - 924. [Abstract] [Full Text] [PDF]

				F. Nicolini, C. Beghi, C. Muscari, A. Agostinelli, A. M. Budillon, I. Spaggiari, and T. Gherli Myocardial protection in adult cardiac surgery: current options and future challenges Eur. J. Cardiothorac. Surg., December 1, 2003; 24(6): 986 - 993. [Abstract] [Full Text] [PDF]

				M. Carrier, M. Pellerin, L. P. Perrault, D. Bouchard, P. Page, N. Searle, and J. Lavoie Cardioplegic arrest with L-arginine improves myocardial protection: results of a prospective randomized clinical trial Ann. Thorac. Surg., March 1, 2002; 73(3): 837 - 841. [Abstract] [Full Text] [PDF]

				Y. Yan, S. Davani, S. Chocron, B. Kantelip, P. Muret, and J.-P. Kantelip Effects of L-arginine administration before cardioplegic arrest on ischemia-reperfusion injury Ann. Thorac. Surg., December 1, 2001; 72(6): 1985 - 1990. [Abstract] [Full Text] [PDF]

				Y. Liu, Q. Wang, X. Zhu, D. Liu, S. Pan, Y. Ruan, and Y. Li Pulmonary artery perfusion with protective solution reduces lung injury after cardiopulmonary bypass Ann. Thorac. Surg., May 1, 2000; 69(5): 1402 - 1407. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi DOSE DEPENDENCY OF L-ARGININE IN NEONATAL MYOCARDIAL PROTECTION: THE NITRIC OXIDE PARADOX J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 655 - 664. [Abstract] [Full Text] [PDF]

				M. T. Kronon, B. S. Allen, A. Halldorsson, S. Rahman, T. Wang, and M. Ilbawi L-ARGININE, PROSTAGLANDIN, AND WHITE CELL FILTRATION EQUALLY IMPROVE MYOCARDIAL PROTECTION IN STRESSED NEONATAL HEARTS J. Thorac. Cardiovasc. Surg., October 1, 1999; 118(4): 665 - 673. [Abstract] [Full Text] [PDF]

				P. E. Parrino, V. E. Laubach, J. R. Gaughen Jr, K. S. Shockey, T.-A. Wattsman, R. C. King, C. G. Tribble, and I. L. Kron Inhibition of inducible nitric oxide synthase after myocardial ischemia increases coronary flow Ann. Thorac. Surg., September 1, 1998; 66(3): 733 - 739. [Abstract] [Full Text] [PDF]

				M. Carrier, M. Pellerin, P. L. Page, N. R. Searle, R. Martineau, C. Caron, B. C. Solymoss, and L. C. Pelletier Can L-arginine improve myocardial protection during cardioplegic arrest? Results of a phase I pilot study Ann. Thorac. Surg., July 1, 1998; 66(1): 108 - 112. [Abstract] [Full Text] [PDF]